Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyasu Yamashiro

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 2010
[Basic fibroblast growth factor (FGF-2)]Wakako Tsuji, Hiroyasu Yamashiro, Masakazu Toi
Asian Journal of Surgery|July 1, 2021
Can the dissection device with low thermal injury prevent breast cancer-related arm lymphedema? A retrospective cohort studyHaruko Takuwa, Emi Izaki, Hiroyasu Yamashiro, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Trastuzumab treatment for breast cancer]Hiroyasu Yamashiro, Kazumi Toyama, Hiroko Bando, et al.
Journal of Tissue Engineering and Regenerative Medicine|October 16, 2009
In situ adipogenesis in fat tissue augmented by collagen scaffold with gelatin microspheres containing basic fibroblast growth factorYu Kimura, Wakako Tsuji, Hiroyasu Yamashiro, et al.
Tissue Engineering|July 19, 2006
In situ regeneration of adipose tissue in rat fat pad by combining a collagen scaffold with gelatin microspheres containing basic fibroblast growth factorYosuke Hiraoka, Hiroyasu Yamashiro, Kaori Yasuda, et al.
Breast Cancer (Tokyo, Japan)|November 16, 2005
Pathophysiology of seroma in breast cancerKatsumasa Kuroi, Kojiro Shimozuma, Tetsuya Taguchi, et al.
Breast Cancer (Tokyo, Japan)|August 25, 2006
Effect of mechanical closure of dead space on seroma formation after breast surgeryKatsumasa Kuroi, Kojiro Shimozuma, Tetsuya Taguchi, et al.
Oncology Letters|April 29, 2016
Pathological complete response rate in hormone receptor-negative breast cancer treated with neoadjuvant FEC, followed by weekly paclitaxel administration: A retrospective study and review of the literatureTakayoshi Kiba, Nao Morii, Hirotoshi Takahashi, et al.
Breast Cancer (Dove Medical Press)|September 11, 2015
Pathological response rate in hormone-positive breast cancer patients treated with neoadjuvant FEC and triweekly docetaxel: a case seriesTakayoshi Kiba, Nao Morii, Hirotoshi Takahashi, et al.
Japanese Journal of Clinical Oncology|May 11, 2006
Evidence-based risk factors for seroma formation in breast surgeryKatsumasa Kuroi, Kojiro Shimozuma, Tetsuya Taguchi, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 2010
[Basic fibroblast growth factor (FGF-2)]Wakako Tsuji, Hiroyasu Yamashiro, Masakazu Toi
Asian Journal of Surgery|July 1, 2021
Can the dissection device with low thermal injury prevent breast cancer-related arm lymphedema? A retrospective cohort studyHaruko Takuwa, Emi Izaki, Hiroyasu Yamashiro, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Trastuzumab treatment for breast cancer]Hiroyasu Yamashiro, Kazumi Toyama, Hiroko Bando, et al.
Journal of Tissue Engineering and Regenerative Medicine|October 16, 2009
In situ adipogenesis in fat tissue augmented by collagen scaffold with gelatin microspheres containing basic fibroblast growth factorYu Kimura, Wakako Tsuji, Hiroyasu Yamashiro, et al.
Tissue Engineering|July 19, 2006
In situ regeneration of adipose tissue in rat fat pad by combining a collagen scaffold with gelatin microspheres containing basic fibroblast growth factorYosuke Hiraoka, Hiroyasu Yamashiro, Kaori Yasuda, et al.
Breast Cancer (Tokyo, Japan)|November 16, 2005
Pathophysiology of seroma in breast cancerKatsumasa Kuroi, Kojiro Shimozuma, Tetsuya Taguchi, et al.
Breast Cancer (Tokyo, Japan)|August 25, 2006
Effect of mechanical closure of dead space on seroma formation after breast surgeryKatsumasa Kuroi, Kojiro Shimozuma, Tetsuya Taguchi, et al.
Oncology Letters|April 29, 2016
Pathological complete response rate in hormone receptor-negative breast cancer treated with neoadjuvant FEC, followed by weekly paclitaxel administration: A retrospective study and review of the literatureTakayoshi Kiba, Nao Morii, Hirotoshi Takahashi, et al.
Breast Cancer (Dove Medical Press)|September 11, 2015
Pathological response rate in hormone-positive breast cancer patients treated with neoadjuvant FEC and triweekly docetaxel: a case seriesTakayoshi Kiba, Nao Morii, Hirotoshi Takahashi, et al.
Japanese Journal of Clinical Oncology|May 11, 2006
Evidence-based risk factors for seroma formation in breast surgeryKatsumasa Kuroi, Kojiro Shimozuma, Tetsuya Taguchi, et al.
Pageof 5